Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,525 Cr
up ₹155 Cr vs Jun 2023
- Stocks held
- 24
- unchanged
- Top 10 weight
- 69.0%
- of the portfolio in its ten largest
- Cash & debt
- 2.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 5
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2023 it disclosed 24 stocks worth ₹1,525 Cr, up ₹155 Cr from Jun 2023. Its largest positions were Sun Pharmaceutical Industries Limited (15.3%), Cipla Limited (10.1%), Lupin Limited (6.6%); the ten largest together made up 69.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 72.4% of its equity. Cash and debt stood at 2.9%. Compared with Jun 2023 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
40%
Holds more cash than 40% of peers
What these mean: concentration · cash
Holdings in July 2023
Download CSVEvery line the fund disclosed, with the change against Jun 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 15.28% | down 0.36 pts | ₹233 Cr | up ₹18.7 Cr | Added |
| Cipla Limited | 10.12% | up 0.39 pts | ₹154 Cr | up ₹21 Cr | Added |
| Lupin Limited | 6.59% | down 0.13 pts | ₹100 Cr | up ₹8.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 6.32% | down 0.61 pts | ₹96.3 Cr | up ₹1.4 Cr | Added |
| Alembic Pharmaceuticals Limited | 6.26% | up 0.83 pts | ₹95.5 Cr | up ₹21.1 Cr | Added |
| Suven Pharmaceuticals Limited | 5.88% | up 1.32 pts | ₹89.6 Cr | up ₹27.2 Cr | Added |
| Procter & Gamble Health Limited | 5.60% | down 0.49 pts | ₹85.4 Cr | up ₹2 Cr | Added |
| Alkem Laboratories Limited | 4.90% | up 0.08 pts | ₹74.7 Cr | up ₹8.7 Cr | Added |
| IPCA Laboratories Limited | 4.78% | up 0.25 pts | ₹72.8 Cr | up ₹10.9 Cr | Added |
| Intuitive Surgical Inc | 3.28% | down 0.56 pts | ₹50.1 Cr | down ₹2.5 Cr | Trimmed |
| Zydus Lifesciences Limited | 3.17% | down 0.08 pts | ₹48.4 Cr | up ₹3.8 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.00% | down 0.51 pts | ₹45.8 Cr | down ₹2.4 Cr | Trimmed |
| Aarti Drugs Limited | 2.90% | up 0.37 pts | ₹44.2 Cr | up ₹9.6 Cr | Added |
| Cash, TREPS & receivables | 2.85% | up 1.95 pts | ₹43.5 Cr | up ₹31.1 Cr | Added |
| Indoco Remedies Limited | 2.63% | down 0.39 pts | ₹40.1 Cr | down ₹1.2 Cr | Trimmed |
| Mankind Pharma Limited | 2.23% | down 2.06 pts | ₹33.9 Cr | down ₹24.8 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.19% | down 0.18 pts | ₹33.4 Cr | up ₹99 L | Added |
| Globus Medical Inc | 2.18% | down 0.21 pts | ₹33.2 Cr | up ₹52 L | Added |
| Kovai Medical Center and Hospital Limited | 2.04% | up 0.15 pts | ₹31 Cr | up ₹5.2 Cr | Added |
| Abbott Laboratories | 1.90% | down 0.16 pts | ₹28.9 Cr | up ₹78 L | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.32% | down 0.14 pts | ₹20.1 Cr | up ₹13 L | Added |
| Taro Pharmaceutical Industries Limited | 1.25% | down 0.20 pts | ₹19.1 Cr | down ₹74 L | Trimmed |
| MedPlus Health Services Limited | 1.21% | up 0.12 pts | ₹18.4 Cr | up ₹3.5 Cr | Added |
| Illumina Inc | 0.87% | down 0.08 pts | ₹13.3 Cr | up ₹24 L | Added |
| Unichem Laboratories Limited | 0.86% | up 0.71 pts | ₹13.1 Cr | up ₹11 Cr | Added |
| Pfizer Limited | 0.40% | down 0.02 pts | ₹6.1 Cr | up ₹33 L | Added |
What changed, Jun 2023 to Jul 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹27.2 Cr (+1.32% pts)
- Alembic Pharmaceuticals Limitedup ₹21.1 Cr (+0.83% pts)
- Cipla Limitedup ₹21 Cr (+0.39% pts)
- Sun Pharmaceutical Industries Limitedup ₹18.7 Cr (−0.36% pts)
- Unichem Laboratories Limited ₹11 Cr (+0.71% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2023, the weight rose most in Pharmaceuticals & Biotechnology (+1.2 pts) and Pharmaceuticals (+0.3 pts), and fell most in Healthcare Services (−0.8 pts) and Healthcare Equipment & Supplies (−0.7 pts).
- Pharmaceuticals & Biotechnology71.1% → 72.4%+1.2 pts
- Pharmaceuticals5.4% → 5.6%+0.3 pts
- Retailing1.1% → 1.3%+0.1 pts
- Healthcare Services13.6% → 12.8%−0.8 pts
- Healthcare Equipment & Supplies6.4% → 5.7%−0.7 pts
- Insurance2.4% → 2.3%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2020 | Jul 2022 | Jan 2023 | Apr 2023 | Jun 2023 | Jul 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.7% | 57.0% | 67.6% | 69.5% | 71.1% | 72.4% |
| Healthcare Services | 17.2% | 26.0% | 16.6% | 15.1% | 13.6% | 12.8% |
| Healthcare Equipment & Supplies | 3.0% | 5.6% | 6.6% | 6.4% | 6.4% | 5.7% |
| Pharmaceuticals | 9.6% | 7.7% | 5.8% | 5.7% | 5.4% | 5.6% |
| Insurance | 3.5% | 2.5% | 2.3% | 2.1% | 2.4% | 2.3% |
| Retailing | — | 1.2% | 1.0% | 1.2% | 1.1% | 1.3% |
Allocation in Jul 2023change vs Jun 2023
- Pharmaceuticals & Biotechnology (13)72.4%▲ 1.2 pts
- Healthcare Services (4)12.8%▼ 0.8 pts
- Healthcare Equipment & Supplies (2)5.7%▼ 0.7 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jul 2023
2.9%
▲ 2.0 pts vs Jun 2023
- Cash alone
- 2.8%
- cash and net receivables
- A year earlier
- −<0.1%
- Jul 2022 · now ▲ 2.9 pts
- Last 12 months
- <0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.